Biobanking is now a key discipline in cancer research and its infrastructure. This helps accelerate translational research and is typically pathology-led. To use biobanked tissues to best effect, sample quality is paramount, and biobanks have a responsibility to ensure this is achieved. In 2016, the National Cancer Research Institute (NCRI) established the Cellular & Molecular Pathology initiative (CM-Path), which aims to re-invigorate UK academic pathology in the UK. One of the goals of the CM-Path biobanking subgroup group was to create a Biobanking Sample Quality Improvement Tool. The tool is a confidential self-assessment of current practices within a biobank, focusing on tissue quality and identifying areas with the potential for improvement. Here we describe the development and implementation of this tool and discuss what it can offer to the cancer biobanking community.
|Journal||Biopreservation and Biobanking|
|Publication status||Accepted/In press - 13 May 2020|